HEPA logo

Hepion Pharmaceuticals (HEPA)

Profile

Full Name

Hepion Pharmaceuticals, Inc.

Ticker Symbol

HEPA

Exchange

NASDAQ

Country

United States

IPO

February 10, 2014

Indexes

Not included

Employees

22

Key Details

Price

$0.32(-6.09%)

Market cap

$347.87K(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$5367.50(+82.58% YoY)

PE ratio

-

Next earnings date

May 21, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Dec 7, 23 Brookline Capital
Hold
Feb 28, 22 Cantor Fitzgerald
Overweight
Nov 22, 19 Brookline Capital
Buy

Institutional Ownership

  • What is the ticker symbol for Hepion Pharmaceuticals?
  • Does Hepion Pharmaceuticals pay dividends?
  • What sector is Hepion Pharmaceuticals in?
  • What industry is Hepion Pharmaceuticals in?
  • What country is Hepion Pharmaceuticals based in?
  • When did Hepion Pharmaceuticals go public?
  • Is Hepion Pharmaceuticals in the S&P 500?
  • Is Hepion Pharmaceuticals in the NASDAQ 100?
  • Is Hepion Pharmaceuticals in the Dow Jones?
  • When was Hepion Pharmaceuticals's last earnings report?
  • When does Hepion Pharmaceuticals report earnings?
  • Should I buy Hepion Pharmaceuticals stock now?

What is the ticker symbol for Hepion Pharmaceuticals?

The ticker symbol for Hepion Pharmaceuticals is NASDAQ:HEPA

Does Hepion Pharmaceuticals pay dividends?

No, Hepion Pharmaceuticals does not pay dividends

What sector is Hepion Pharmaceuticals in?

Hepion Pharmaceuticals is in the Healthcare sector

What industry is Hepion Pharmaceuticals in?

Hepion Pharmaceuticals is in the Biotechnology industry

What country is Hepion Pharmaceuticals based in?

Hepion Pharmaceuticals is headquartered in United States

When did Hepion Pharmaceuticals go public?

Hepion Pharmaceuticals's initial public offering (IPO) was on February 10, 2014

Is Hepion Pharmaceuticals in the S&P 500?

No, Hepion Pharmaceuticals is not included in the S&P 500 index

Is Hepion Pharmaceuticals in the NASDAQ 100?

No, Hepion Pharmaceuticals is not included in the NASDAQ 100 index

Is Hepion Pharmaceuticals in the Dow Jones?

No, Hepion Pharmaceuticals is not included in the Dow Jones index

When was Hepion Pharmaceuticals's last earnings report?

Hepion Pharmaceuticals's most recent earnings report was on Nov 14, 2024

When does Hepion Pharmaceuticals report earnings?

The next expected earnings date for Hepion Pharmaceuticals is May 21, 2025

Should I buy Hepion Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page